Clark Michael's Insider Trades & SAST Disclosures
Clark Michael's most recent trade in FG Financial Group Inc was a trade of 10,000 8.00% Cumulative Preferred Stock, Series A, $25.00 par value done at an average price of $16.4 . Disclosure was reported to the exchange on May 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Clark Michael.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| FG Financial Group Inc | Michael Clark Mitchell | Director | Purchase of securities on an exchange or from another person at price $ 16.44 per share. | 21 May 2025 | 10,000 | 13,064 | - | 16.4 | 164,450 | 8.00% Cumulative Preferred Stock, Series A, $25.00 par value |
| FG Financial Group Inc | Michael Clark Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 2,944 | 17,718 (0%) | 0% | 0 | Common Stock | |
| FG Financial Group Inc | Michael Clark Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 1,284 | 14,774 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | SVP - Policy & Administration | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.28 per share. | 03 Mar 2025 | 1,448 | 105,123 (0%) | 0% | 42.3 | 61,218 | Common Stock |
| LKQ Corp | Michael Clark | SVP - Policy & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 7,270 | 106,572 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | SVP - Policy & Administration | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.60 per share. | 20 Feb 2025 | 879 | 99,302 (0%) | 0% | 41.6 | 36,569 | Common Stock |
| LKQ Corp | Michael Clark | SVP - Policy & Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 620 | 100,181 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 52,338 | 368,854 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.57 per share. | 11 Feb 2025 | 20,593 | 348,261 (0%) | 0% | 9.6 | 197,075 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 125,430 | 125,430 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 69,228 | 331,195 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 11,987 | 319,208 (0%) | 0% | 9.4 | 112,798 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.31 per share. | 02 Jan 2025 | 5,381 | 261,967 (0%) | 0% | 9.3 | 50,097 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.41 per share. | 02 Jan 2025 | 2,692 | 316,516 (0%) | 0% | 9.4 | 25,332 | Common Stock |
| FG Financial Group Inc | Michael Clark Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Nov 2024 | 606 | 13,490 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | SVP - Policy & Administration | Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.35 per share. | 03 Sep 2024 | 941 | 99,560 (0%) | 0% | 41.4 | 38,912 | Common Stock |
| Linkbancorp Inc | Michael W. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 2,000 | 64,058 | - | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.99 per share. | 01 Mar 2024 | 1,619 | 100,502 (0%) | 0% | 52.0 | 84,165 | Common Stock |
| FG Financial Group Inc | Michael Clark Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 66,777 | 286,095 (4%) | 1% | - | Common Stock | |
| FG Financial Group Inc | Michael Clark Mitchell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 20,833 | 306,928 (5%) | 0% | - | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 6,914 | 102,121 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Clark Michael | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 5,202 | 98,057 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 51.80 per share. | 22 Feb 2024 | 2,850 | 95,207 (0%) | 0% | 51.8 | 147,620 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Feb 2024 | 4,427 | 253,664 (0%) | 0% | 14 | 61,978 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jan 2024 | 13,684 | 280,389 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 258,091 (0%) | 0% | 13.6 | 117,581 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.65 per share. | 09 Jan 2024 | 8,614 | 271,775 (0%) | 0% | 13.6 | 117,581 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 8,726 | 268,089 (0%) | 0% | 14 | 122,164 | Common Stock |
| Amicus Therapeutics Inc | Michael David Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 08 Jan 2024 | 1,384 | 266,705 (0%) | 0% | 14 | 19,376 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.44 per share. | 04 Jan 2024 | 2,692 | 276,815 (0%) | 0% | 13.4 | 36,180 | Common Stock |
| Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 83,221 | 83,221 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Clark David Michael | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 48,209 | 297,488 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.53 per share. | 02 Jan 2024 | 11,650 | 279,507 (0%) | 0% | 13.5 | 157,625 | Common Stock |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.24 per share. | 02 Jan 2024 | 6,331 | 291,157 (0%) | 0% | 14.2 | 90,153 | Common Stock |
| Amicus Therapeutics Inc | Clark Michael David | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2023 | 8,212 | 249,279 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.82 per share. | 01 Sep 2023 | 1,075 | 92,855 (0%) | 0% | 52.8 | 56,785 | Common Stock |
| Workhorse Group Inc | Michael L. Clark | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 May 2023 | 24,752 | 116,254 (0%) | 0% | 0 | Common Stock, $0.001 par value per share | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 57.30 per share. | 01 Mar 2023 | 1,677 | 93,930 (0%) | 0% | 57.3 | 96,092 | Common Stock |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 5,966 | 95,607 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 4,677 | 92,302 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.74 per share. | 23 Feb 2023 | 2,661 | 89,641 (0%) | 0% | 55.7 | 148,313 | Common Stock |
| Workhorse Group Inc | Michael L. Clark | Director | Grant, award, or other acquisition of securities at price $ 2.02 per share. | 22 Feb 2023 | 49,505 | 141,006 (0%) | 0% | 2.0 | 100,000 | Common Stock, $0.001 par value per share |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 13.50 per share. | 18 Jan 2023 | 7,382 | 241,067 (0%) | 0% | 13.5 | 99,657 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 47,621 | 267,187 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.02 per share. | 11 Jan 2023 | 18,738 | 248,449 (0%) | 0% | 12.0 | 225,231 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 11.87 per share. | 04 Jan 2023 | 21,507 | 219,566 (0%) | 0% | 11.9 | 255,346 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.03 per share. | 04 Jan 2023 | 2,692 | 241,073 (0%) | 0% | 12.0 | 32,385 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 105,388 | 105,388 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 59,372 | 249,575 (0%) | 0% | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.21 per share. | 02 Jan 2023 | 11,336 | 198,696 (0%) | 0% | 12.2 | 138,413 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.03 per share. | 02 Jan 2023 | 8,493 | 190,203 (0%) | 0% | 12.0 | 102,176 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.93 per share. | 02 Jan 2023 | 5,810 | 243,765 (0%) | 0% | 11.9 | 69,313 | Common Stock |
| Workhorse Group Inc | Michael L. Clark | Director | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 12 Dec 2022 | 39,823 | 91,501 (0%) | 0% | 1.9 | 73,673 | Common Stock, $0.001 par value per share |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.40 per share. | 09 Oct 2022 | 5,510 | 210,032 (0%) | 0% | 10.4 | 57,304 | Common Stock |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 53.05 per share. | 01 Sep 2022 | 1,178 | 87,625 (0%) | 0% | 53.1 | 62,494 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 05 Aug 2022 | 11,322 | 215,542 (0%) | 0% | 12.5 | 141,525 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 2,268 | 0 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 2,268 | 13,998 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 610 | 11,730 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 May 2022 | 220 | 12,340 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Other type of transaction at price $ 31.52 per share. | 13 Apr 2022 | 80 | 2,249 (0%) | 0% | 31.5 | 2,522 | Common Stock |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.20 per share. | 01 Mar 2022 | 1,818 | 88,803 (0%) | 0% | 46.2 | 83,995 | Common Stock |
| Workhorse Group Inc | Michael L. Clark | Director | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 23 Feb 2022 | 33,003 | 131,324 (0%) | 0% | 3.0 | 99,999 | Common Stock, $0.001 par value per share |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 6,747 | 90,621 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,467 | 86,091 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.65 per share. | 17 Feb 2022 | 2,217 | 83,874 (0%) | 0% | 48.7 | 107,867 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 1,000 | 1,000 | - | - | Director Stock Option (Right to Buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 108,266 | 108,266 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 59,071 | 207,313 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 32,235 | 239,548 (0%) | 0% | - | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.53 per share. | 14 Jan 2022 | 12,684 | 226,864 (0%) | 0% | 10.5 | 133,563 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Oct 2021 | 27,000 | 203,112 | - | 0 | Common Stock | |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.51 per share. | 09 Oct 2021 | 5,510 | 168,879 (0%) | 0% | 11.5 | 63,420 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 8.33 per share. | 01 Oct 2021 | 360 | 176,112 | - | 8.3 | 2,999 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 8.36 per share. | 29 Sep 2021 | 395 | 175,752 | - | 8.4 | 3,302 | Common Stock |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.04 per share. | 01 Sep 2021 | 1,244 | 82,624 (0%) | 0% | 52.0 | 64,739 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Aug 2021 | 708 | 12,926 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Other type of transaction at price $ 35.74 per share. | 11 Aug 2021 | 192 | 1,925 (0%) | 0% | 35.7 | 6,862 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 8.52 per share. | 21 Jul 2021 | 1,209 | 175,357 | - | 8.5 | 10,296 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Other type of transaction at price $ 36.09 per share. | 14 Jul 2021 | 191 | 1,671 (0%) | 0% | 36.1 | 6,893 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 8.05 per share. | 17 May 2021 | 20,561 | 174,148 | - | 8.0 | 165,516 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.68 per share. | 06 May 2021 | 13,560 | 153,587 | - | 7.7 | 104,077 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.68 per share. | 06 May 2021 | 3,638 | 140,027 | - | 7.7 | 27,954 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.77 per share. | 04 May 2021 | 12,500 | 116,939 | - | 7.8 | 97,083 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 04 May 2021 | 11,950 | 131,889 | - | 7.7 | 91,597 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 04 May 2021 | 4,500 | 136,389 | - | 7.7 | 34,521 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.67 per share. | 04 May 2021 | 2,500 | 119,439 | - | 7.7 | 19,175 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.68 per share. | 04 May 2021 | 500 | 119,939 | - | 7.7 | 3,840 | Common Stock |
| Amicus Therapeutics Inc | David Michael Clark | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2021 | 16,883 | 174,389 (0%) | 0% | 0 | Common Stock | |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.37 per share. | 15 Mar 2021 | 5,000 | 104,439 | - | 7.4 | 36,850 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 7.38 per share. | 10 Mar 2021 | 43,500 | 99,439 | - | 7.4 | 320,813 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Mar 2021 | 600 | 13,258 (0%) | 0% | 0 | Common Stock | |
| Arrow Financial Corp. | Michael B. Clarke | Director | Other type of transaction at price $ 33.93 per share. | 05 Mar 2021 | 203 | 1,470 (0%) | 0% | 33.9 | 6,888 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Mar 2021 | 150 | 13,858 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.46 per share. | 01 Mar 2021 | 1,446 | 83,868 (0%) | 0% | 40.5 | 58,507 | Common Stock |
| Workhorse Group Inc | Michael L. Clark | Director | Grant, award, or other acquisition of securities at price $ 15.13 per share. | 25 Feb 2021 | 3,966 | 98,321 (0%) | 0% | 15.1 | 60,006 | Common Stock, $0.001 par value per share |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,803 | 85,314 (0%) | 0% | 0 | Common Stock | |
| LKQ Corp | Michael Clark | VP of Finance and Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.73 per share. | 18 Feb 2021 | 470 | 77,511 (0%) | 0% | 38.7 | 18,201 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 6.75 per share. | 12 Feb 2021 | 5,423 | 55,939 | - | 6.7 | 36,605 | Common Stock |
| Partners Bancorp | Michael W. Clarke | Director | Purchase of securities on an exchange or from another person at price $ 6.78 per share. | 11 Feb 2021 | 18 | 47,524 | - | 6.8 | 122 | Common Stock |
| Arrow Financial Corp. | Michael B. Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 1,000 | 1,000 | - | - | Director Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges